About Crestica
Crestica is a Healthcare company based in Hyderabad (India) founded in 2018. It offers pharmaceutical solutions for womens health, infertility, and nutritional needs. It operates on a B2B and B2C model. Its Indian entity Crestica Life Sciences Private Limited reported revenue of ₹2.48 Cr. Crestica offers products and services including Ferrocres XT Tablets, CresBan-21 Tablets, Clara Cu 250, OG Care 200ml Liquid, and Protica - DF. Its focus areas include Pharmaceuticals, Women's Health, Contraception and Nutritional Supplements.
Company details
Crestica Lifesciences , Based In Madurai, Tamil Nadu, India, Develops And Markets Quality Pharmaceutical Products Including Antenatal Care, Contraceptives, Infertility Treatments, And Nutritional Supplements. The Company Focuses On Making Healthcare Accessible Through Effective Medicines At Affordable Prices, Serving The Medical Community And Consumers. With Offices In Multiple States, They Expand Their Presence Across India While Prioritizing Value And Efficacy In Their Offerings.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website crestica.in
- Legal Name Crestica Life Sciences Private Limited
- Date of Incorporation 22 May, 2019
- Jurisdiction Madurai, Tamil Nadu, India
- Annual Revenue₹2.48 Cr
FY 2025 · +28% YoY
- Net Profit₹3.7 Lakh
FY 2025 · 1% margin
- EBITDA₹5 Lakh
FY 2025 · 2% margin
Associated legal entities of Crestica
Crestica operates through Crestica Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Crestica Life Sciences Private Limited CIN U85300TN2019PTC129403 | Active | 22 May 2019 | Madurai, Tamil Nadu | ₹2.5 Cr | 3 | View details |
Products & Services of Crestica
Crestica offers a comprehensive portfolio of products and services, including Ferrocres XT Tablets, CresBan-21 Tablets, Clara Cu 250, OG Care 200ml Liquid, and Protica - DF.
Tablets for supporting antenatal health and nutritional needs
Contraceptive tablets for birth control and family planning
IUCD device for long-term contraception options
Liquid supplement for infertility treatment support
Supplement providing essential nutrients for general health
Antibiotic tablets for treating infections and related conditions
Board of directors of Crestica Life Sciences Private Limited (Crestica)
Crestica Life Sciences Private Limited is the primary company behind Crestica. The board of Crestica Life Sciences Private Limited currently have 3 directors; the longest-serving is Kadar, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kadar DIN 07526929 | Director | 22 May 2019 | 7 yrs 5 mo | Crestica Life Sciences Private Limited |
| Vazhumuni Vinayagam DIN 08459037 | Director | 22 May 2019 | 7 yrs 5 mo | Crestica Life Sciences Private Limited |
| Parameswaran Maruthappa DIN 08459036 | Director | 22 May 2019 | 7 yrs 5 mo | Crestica Life Sciences Private Limited |
Financials of Crestica
Figures of Crestica Life Sciences Private Limited, the primary company behind Crestica, for FY 2025. Revenue was ₹2.48 Cr (+28% year on year). Net profit was ₹3.7 Lakh (1% margin). EBITDA was ₹5 Lakh (2% margin). Revenue has grown at a compounded annual rate of +42% over three years and +67% over five years.
- ₹2.48 CrRevenue · FY 2025 · +28% YoY
- ₹3.7 LakhNet profit · 1% margin
- ₹5 LakhEBITDA · 2% margin
- ₹2.5 LakhPaid-up capital
- +42%Revenue CAGR, 3 years
- +67%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Crestica Life Sciences Private Limited are on its company page.
Detailed financial statements for Crestica
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Crestica
Crestica was founded in 2018.
Crestica is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Crestica, Crestica Life Sciences Private Limited, reported revenue of ₹2.48 Cr for FY 2025, up 28% year on year.
Crestica Lifesciences , Based In Madurai, Tamil Nadu, India, Develops And Markets Quality Pharmaceutical Products Including Antenatal Care, Contraceptives, Infertility Treatments, And Nutritional Supplements. The Company Focuses On Making Healthcare Accessible Through Effective Medicines At Affordable Prices, Serving The Medical Community And Consumers. With Offices In Multiple States, They Expand Their Presence Across India While Prioritizing Value And Efficacy In Their Offerings.
Crestica offers Ferrocres XT Tablets, CresBan-21 Tablets, Clara Cu 250, OG Care 200ml Liquid, and 2 more products and services.
Crestica operates through Crestica Life Sciences Private Limited.
The legal entities of Crestica currently have 3 directors, including Kadar, Vazhumuni Vinayagam, Parameswaran Maruthappa.